These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3874762)

  • 1. [Alpha 1-antitrypsin and the percentage of fecal excretion of 111In-oxin-labeled leukocytes in Crohn disease].
    Fischbach W; Becker W
    Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1233. PubMed ID: 3874762
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease.
    Saverymuttu SH; Peters AM; Lavender JP; Pepys MB; Hodgson HJ; Chadwick VS
    Gastroenterology; 1983 Dec; 85(6):1333-9. PubMed ID: 6628930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inflammatory activity in Crohn's disease].
    Becker W; Fischbach W
    Dtsch Med Wochenschr; 1987 Nov; 112(48):1882. PubMed ID: 3500031
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fecal inflammatory markers in Crohn disease].
    Singe CC
    Z Gastroenterol Verh; 1989 Jul; 24():35-7. PubMed ID: 2474978
    [No Abstract]   [Full Text] [Related]  

  • 5. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease.
    Thomas DW; Sinatra FR; Merritt RJ
    Gastroenterology; 1981 Apr; 80(4):776-82. PubMed ID: 6970702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of intestinal inflammatory activity in Crohn disease using alpha 1-antitrypsin].
    Karbach U; Singe CC; Ewe K
    Dtsch Med Wochenschr; 1985 May; 110(19):778. PubMed ID: 3873330
    [No Abstract]   [Full Text] [Related]  

  • 8. Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases.
    Fischbach W; Becker W; Mössner J; Koch W; Reiners C
    Gut; 1987 Apr; 28(4):386-93. PubMed ID: 3495470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K; Berger M; Niederau C; Frieling T
    Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease.
    Thomas DW; Sinatra FR; Merritt RJ
    J Pediatr Gastroenterol Nutr; 1983; 2(3):491-6. PubMed ID: 6604798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal alpha-1-antitrypsin in chronic inflammatory bowel disease.
    Thomas DW
    Gut; 1988 Feb; 29(2):262-3. PubMed ID: 3257935
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha-1 antitrypsin and electrolytes in some cases of diarrhoea.
    el-Hawy AM; Abou-Taleb SA; Massoud AM; Abdel-Khalek YH
    J Egypt Soc Parasitol; 1989 Jun; 19(1):131-7. PubMed ID: 2785149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of fecal alpha 1-antitrypsin excretion for assessment of inflammatory bowel diseases.
    Becker K; Frieling T; Häussinger D
    Eur J Med Res; 1998 Feb; 3(1-2):65-70. PubMed ID: 9512970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of contaminant indium-114m/indium-114 to indium-111 oxine blood dosimetry.
    Marcus CS; Stabin MG; Watson EE; Kuperus JH
    J Nucl Med; 1985 Sep; 26(9):1091-3. PubMed ID: 3928839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of indium-111 granulocyte scanning and fecal excretion measurement in inflammatory bowel disease--an autoradiographic study.
    Keshavarzian A; Price YE; Peters AM; Lavender JP; Wright NA; Hodgson HJ
    Dig Dis Sci; 1985 Dec; 30(12):1156-60. PubMed ID: 4064866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fecal clearance of alpha 1-antitrypsin in childhood].
    Pilotti G; Capaldi S; Ricci C; Suria G; Sordi MS
    Minerva Pediatr; 1984 May; 36(10):535-9. PubMed ID: 6434923
    [No Abstract]   [Full Text] [Related]  

  • 20. [Appraisal of activity in Crohn's disease. Value of inflammatory tests, deconjugation tests and the absorption of bile salts and alpha l-antitrypsin clearance].
    Gillard C; Deflandre J; Brassinne A
    Acta Gastroenterol Belg; 1984; 47(3):309-16. PubMed ID: 6333769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.